Dynamic Technology Lab’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$263K Buy
+15,035
New +$298K 0.04% 656
2025
Q4
Sell
-9,660
Closed -$266K 1106
2025
Q3
$266K Buy
+9,660
New +$297K 0.05% 599
2020
Q3
Sell
-7,000
Closed -$514K 1368
2020
Q2
$514K Buy
7,000
+2,156
+45% +$169K 0.08% 424
2020
Q1
$280K Buy
4,844
+1,161
+32% +$80.7K 0.05% 617
2019
Q4
$289K Buy
+3,683
New +$271K 0.05% 692
2018
Q3
Sell
-4,013
Closed -$462K 1357
2018
Q2
$462K Buy
+4,013
New +$439K 0.07% 493
2017
Q2
Sell
-8,940
Closed -$515K 1336
2017
Q1
$515K Buy
+8,940
New +$534K 0.12% 293
2016
Q3
Sell
-10,266
Closed -$572K 1171
2016
Q2
$572K Buy
10,266
+6,472
+171% +$390K 0.15% 200
2016
Q1
$230K Buy
+3,794
New +$223K 0.06% 672

Other funds holding USNA

Dynamic Technology Lab's USNA Position: Q1 2026 in Review

Dynamic Technology Lab opened a new position in Usana Health Sciences (USNA) in Q1 2026: 15,035 shares worth $263K. The stake represents 0.04% of the portfolio and ranks #656 among its holdings. This is a return to the name: Dynamic Technology Lab previously reported a position in USNA as recently as Q3 2025.

Dynamic Technology Lab first reported a position in USNA in Q1 2016 and has held it in 9 quarters since. The position peaked at $572K in Q2 2016. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • Dynamic Technology Lab held 15,035 shares of Usana Health Sciences worth $263K as of Q1 2026.
  • Usana Health Sciences was a new Dynamic Technology Lab position in Q1 2026.
  • Usana Health Sciences made up 0.04% of Dynamic Technology Lab's portfolio in Q1 2026, its #656 holding.
  • Dynamic Technology Lab first reported a position in Usana Health Sciences in Q1 2016 and has held it in 9 quarters since.
  • Dynamic Technology Lab's Usana Health Sciences position peaked at $572K in Q2 2016.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Dynamic Technology Lab's 13F filing for Q1 2026, filed 15 May 2026.